{
  "cui": "C0221019",
  "cui_name": "Sickle cell-beta-thalassemia",
  "incidence_per_100k": null,
  "prevalence_per_100k": 1.2,
  "metric_type": "prevalence",
  "total_cases_per_year": 96000,
  "confidence": 0.60,
  "is_subtype": true,
  "parent_disease": "Hemoglobinopathies",
  "reasoning": "Sickle cell-beta-thalassemia (SCD compound heterozygote) reported as prevalence due to chronic hereditary nature. Global prevalence estimated at ~1.2 per 100k based on highest prevalence in sub-Saharan Africa and Mediterranean regions. Confidence moderate due to limited systematic registry data.",
  "data_quality": "moderate",
  "geographic_variation": "high",
  "year_specific": false,
  "data_year": null,
  "source": "WHO Global Burden of Disease estimates for hemoglobinopathies",
  "source_url": null,
  "source_type": null
}
